ASPIRIN

Product NDC: 41226-481
11-digit product format: 412260481
Labeler code: 41226
Product ID: 41226-481_3f2389df-b5d8-1dfd-e063-6294a90a6e99
Type: HUMAN OTC DRUG
Nonproprietary name: ASPIRIN
Dosage form: TABLET, COATED
Route: ORAL
Labeler: Kroger Company
Application: M013
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2021-04-10
Substance: ASPIRIN
Active strength: 81 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 40 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-12	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-50	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-31	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	41226-481-20	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-50	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-31	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	41226-481-20	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-50	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-31	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	41226-481-20	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-50	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-31	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	41226-481-20	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-50	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-31	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	41226-481-20	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-31	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-12	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-20	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	41226-481-50	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-31	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-12	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-20	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	41226-481-50	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-31	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-12	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-20	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	41226-481-50	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ASPIRIN
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ASPIRIN	81 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
R16CO5Y76E	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
308416	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bbee8ee4-e09d-3ba6-e053-2a95a90af647	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
41226-481-12	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-20	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-31	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-50	2025-09-23	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-12	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-20	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-31	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets
41226-481-50	2025-01-30	481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
41226-481-12	ASPIRIN	1 in 1 CARTON	TABLET, COATED	1	4
41226-481-12	ASPIRIN	120 in 1 BOTTLE	TABLET, COATED	120	4
41226-481-20	ASPIRIN	200 in 1 BOTTLE	TABLET, COATED	200	4
41226-481-20	ASPIRIN	1 in 1 CARTON	TABLET, COATED	1	4
41226-481-31	ASPIRIN	300 in 1 BOTTLE	TABLET, COATED	300	4
41226-481-50	ASPIRIN	500 in 1 BOTTLE	TABLET, COATED	500	4
41226-481-50	ASPIRIN	1 in 1 BOTTLE	TABLET, COATED	1	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
41226-481	ASPIRIN TABLET, COATED [KROGER COMPANY]	3	Current NDC, Legacy NDC, 7 package rows	20210616_bbee8ee4-e09d-3ba6-e053-2a95a90af647.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 32 of 79 · 1,579 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Low Dose Aspiriun	ASPIRIN	AMERIFOODS TRADING COMPANY	3802c96a-5e2a-ba9c-e063-6394a90abb78	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227aeb1-dd2c-9ca1-e063-6294a90ad709	2025-11-20	Warnings	Exact identifier application number: M013
good sense pain relief	ACETAMINOPHEN	NuCare Pharamceuticals, Inc.	440c13d7-edf0-f611-e063-6394a90af995	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	4227a2cc-69fa-869d-e063-6294a90a1d41	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	422796ed-7558-f7e8-e063-6294a90ad1c7	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief	ACETAMINOPHEN	HYVEE INC	3e61abe4-b4be-01af-e063-6394a90a8b24	2025-11-20	Warnings	Exact identifier application number: M013
Pain Relief PM	ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE	HYVEE INC	3e60703b-a5cf-333a-e063-6394a90a2087	2025-11-20	Warnings	Exact identifier application number: M013
ASPIRIN	ASPIRIN	CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED	54e4ae54-caf8-4105-8428-256f56a2f68f	2025-11-19	Warnings	Exact identifier application number: M013
MIDOL COMPLETE	ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE	R J General Corporation	0c09a178-1a07-4079-b4a6-d1657cb8e714	2025-11-17	Warnings	Exact identifier application number: M013
Alka-Seltzer Original	ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE	R J General Corporation	dbb0d067-71f0-45e4-bc98-548cf4a90b3a	2025-11-17	Warnings	Exact identifier application number: M013
MOTRIN IB	IBUPROFEN	R J General Corporation	afa87bb5-7fcb-4ccd-acac-f7931242181f	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	99e45e83-37a3-44df-9a2a-98ba7457a5bb	2025-11-17	Warnings	Exact identifier application number: M013
TYLENOL PM EXTRA STRENGTH	ACETAMINOPHEN	R J General Corporation	a40ea0e3-d666-4605-b5e0-beeaf8f586f2	2025-11-17	Warnings	Exact identifier application number: M013
Acetaminophen 250 mg and Ibuprofen 125 mg	ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG	R J General Corporation	68d3be55-9340-4cc9-a05a-12b9338ddc56	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	dd9aaf80-6c2b-41a3-87b9-61642aaed4f0	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c18a2da-1718-4c00-aea8-9fb4a3418312	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	cd3060a5-3b90-42e4-89cd-3b620859045f	2025-11-17	Warnings	Exact identifier application number: M013
Ibuprofen 200 mg	IBUPROFEN	R J General Corporation	1c7221ae-52d1-4d18-b586-c47ff656150d	2025-11-17	Warnings	Exact identifier application number: M013
Excedrin Extra Strength Headache	ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE	R J General Corporation	907c89e7-2482-465f-9f85-2381ecab1b86	2025-11-17	Warnings	Exact identifier application number: M013
Bayer Genuine Aspirin	ASPIRIN	R J General Corporation	23daa359-d40f-4f64-81be-6d154f41df9f	2025-11-17	Warnings	Exact identifier application number: M013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308416	aspirin 81 MG Delayed Release Oral Tablet	PSN	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4
308416	aspirin 81 MG Delayed Release Oral Tablet	SCD	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4
308416	ASA 81 MG Delayed Release Oral Tablet	SY	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4
308416	aspirin 81 MG Enteric Coated Oral Tablet	SY	bbee8ee4-e09d-3ba6-e053-2a95a90af647	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
41226-481-12	41226048112	1 BOTTLE in 1 CARTON (41226-481-12) / 120 TABLET, COATED in 1 BOTTLE	1 bottle	2021-06-12	0000-00-00	No	No	Current
41226-481-20	41226048120	1 BOTTLE in 1 CARTON (41226-481-20) / 200 TABLET, COATED in 1 BOTTLE	1 bottle	2021-06-12	0000-00-00	No	No	Current
41226-481-31	41226048131	300 TABLET, COATED in 1 BOTTLE (41226-481-31)		2021-06-12	0000-00-00	No	No	Current
41226-481-50	41226048150	1 BOTTLE in 1 BOTTLE (41226-481-50) / 500 TABLET, COATED in 1 BOTTLE	1 bottle	2021-04-10	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
481R Kroger 41226-481 Aspirin 81 mg Delayed-Release Tablets	Kroger Company \| Time Cap Laboratories, Inc.	2025-09-19	HUMAN OTC DRUG LABEL	4